Income Tax Expense (Benefit) in USD of Silo Pharma, Inc. from Q3 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Silo Pharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2021 to Q1 2023.
  • Silo Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $906K, a 50.3% increase year-over-year.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)

Silo Pharma, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $906K +$303K +50.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q1 2022 $603K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $19.1K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10

Silo Pharma, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $24.9K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.